“…In addition, several studies have reported increased visfatin levels in type 2 diabetes mellitus with or without any correlation with insulin resistance [9,10,11]. Still other studies have reported the effects of visfatin in other conditions, such as metabolic syndrome [12,13,25,26], cardiovascular disease [12,15,26,27,28] and inflammatory status [11,15,16,17,18]. …”